CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 100 enrolled
Drug / intervention
Pneumococcal Vaccine +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00239694
NCT00239694Phase 4Completed
CompareCT.gov

Immunogenicity of Pneumococcal Vaccination and Revaccination in Older Adults

National Institute on Aging (NIA)·interventional·Posted Oct 17, 2005·Updated Aug 4, 2015

In Brief

A Phase 4 clinical trial evaluating Pneumococcal Vaccine and Meningococcal Vaccine for Aging. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The purpose of this study is to measure how long the improvement in the immune system lasts in older people after they have been vaccinated, and to examine the immune response in older people who get vaccinated a second time.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAging
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 17, 2005
Enrollment StartApr 1, 2001
Primary CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 11.3 yearsPosted 20.7 years ago

Interventions

Pneumococcal Vaccinebiological

One time preventative vaccine

Meningococcal Vaccinebiological

One time preventative vaccine